▼ -5.76% Downside Potential
This price target is based on 11 analysts offering 12 month price targets for Marsh & McLennan Companies in the last 3 months. The average price target is $130.92, with a high forecast of $145.00 and a low forecast of $113.00. The average price target represents a -5.76% upside from the last price of $138.92.
The current consensus among 11 investment analysts is to hold stock in Marsh & McLennan Companies. This rating has held steady since August 2020, when it changed from a Buy consensus rating.
Marsh & McLennan Companies, Inc., a professional services company, provides advice and solutions to clients in the areas of risk, strategy, and people worldwide. It operates in two segments, Risk and Insurance Services, and Consulting. The Risk and Insurance Services segment offers risk management services, such as risk advice, risk transfer, and risk control and mitigation solutions, as well as insurance and reinsurance broking, catastrophe and financial modeling, and related advisory services; and insurance program management services. This segment serves businesses, public entities, insurance companies, associations, professional services organizations, and private clients. The Consulting segment provides health, wealth, and career consulting services and products; and specialized management, as well as economic and brand consulting services. Marsh & McLennan Companies, Inc. has collaboration with Chubb Limited to secure insurance coverage for the COVAX no-fault compensation program. The company was founded in 1871 and is headquartered in New York, New York.